Index
1 Market Overview of Brain Tumor Therapeutics
1.1 Brain Tumor Therapeutics Market Overview
1.1.1 Brain Tumor Therapeutics Product Scope
1.1.2 Brain Tumor Therapeutics Market Status and Outlook
1.2 Global Brain Tumor Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Brain Tumor Therapeutics Market Size by Region (2018-2029)
1.4 Global Brain Tumor Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Brain Tumor Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Brain Tumor Therapeutics Market Size (2018-2029)
1.6.1 North America Brain Tumor Therapeutics Market Size (2018-2029)
1.6.2 Europe Brain Tumor Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Brain Tumor Therapeutics Market Size (2018-2029)
1.6.4 Latin America Brain Tumor Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Brain Tumor Therapeutics Market Size (2018-2029)
2 Brain Tumor Therapeutics Market by Type
2.1 Introduction
2.1.1 Surgery
2.1.2 Radiation Therapy
2.1.3 Targeted Therapy
2.1.4 Chemotherapy
2.1.5 Immunotherapy
2.2 Global Brain Tumor Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Brain Tumor Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Brain Tumor Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Brain Tumor Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Brain Tumor Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Brain Tumor Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Brain Tumor Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Brain Tumor Therapeutics Revenue Breakdown by Type (2018-2029)
3 Brain Tumor Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Oncology Treatment Centers
3.1.3 Others
3.2 Global Brain Tumor Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Brain Tumor Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Brain Tumor Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Brain Tumor Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Brain Tumor Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Brain Tumor Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Brain Tumor Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Brain Tumor Therapeutics Revenue Breakdown by Application (2018-2029)
4 Brain Tumor Therapeutics Competition Analysis by Players
4.1 Global Brain Tumor Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Brain Tumor Therapeutics as of 2022)
4.3 Date of Key Players Enter into Brain Tumor Therapeutics Market
4.4 Global Top Players Brain Tumor Therapeutics Headquarters and Area Served
4.5 Key Players Brain Tumor Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Brain Tumor Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer Brain Tumor Therapeutics Products, Services and Solutions
5.1.4 Pfizer Brain Tumor Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Pfizer Recent Developments
5.2 Novartis
5.2.1 Novartis Profile
5.2.2 Novartis Main Business
5.2.3 Novartis Brain Tumor Therapeutics Products, Services and Solutions
5.2.4 Novartis Brain Tumor Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Novartis Recent Developments
5.3 Roche
5.3.1 Roche Profile
5.3.2 Roche Main Business
5.3.3 Roche Brain Tumor Therapeutics Products, Services and Solutions
5.3.4 Roche Brain Tumor Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Merck Recent Developments
5.4 Merck
5.4.1 Merck Profile
5.4.2 Merck Main Business
5.4.3 Merck Brain Tumor Therapeutics Products, Services and Solutions
5.4.4 Merck Brain Tumor Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Merck Recent Developments
5.5 AstraZeneca
5.5.1 AstraZeneca Profile
5.5.2 AstraZeneca Main Business
5.5.3 AstraZeneca Brain Tumor Therapeutics Products, Services and Solutions
5.5.4 AstraZeneca Brain Tumor Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 AstraZeneca Recent Developments
5.6 GE Healthcare
5.6.1 GE Healthcare Profile
5.6.2 GE Healthcare Main Business
5.6.3 GE Healthcare Brain Tumor Therapeutics Products, Services and Solutions
5.6.4 GE Healthcare Brain Tumor Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 GE Healthcare Recent Developments
5.7 Hitachi Medical
5.7.1 Hitachi Medical Profile
5.7.2 Hitachi Medical Main Business
5.7.3 Hitachi Medical Brain Tumor Therapeutics Products, Services and Solutions
5.7.4 Hitachi Medical Brain Tumor Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Hitachi Medical Recent Developments
5.8 Philips Healthcare
5.8.1 Philips Healthcare Profile
5.8.2 Philips Healthcare Main Business
5.8.3 Philips Healthcare Brain Tumor Therapeutics Products, Services and Solutions
5.8.4 Philips Healthcare Brain Tumor Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Philips Healthcare Recent Developments
5.9 Novocure
5.9.1 Novocure Profile
5.9.2 Novocure Main Business
5.9.3 Novocure Brain Tumor Therapeutics Products, Services and Solutions
5.9.4 Novocure Brain Tumor Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 Novocure Recent Developments
5.10 DelMar Pharmaceuticals
5.10.1 DelMar Pharmaceuticals Profile
5.10.2 DelMar Pharmaceuticals Main Business
5.10.3 DelMar Pharmaceuticals Brain Tumor Therapeutics Products, Services and Solutions
5.10.4 DelMar Pharmaceuticals Brain Tumor Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 DelMar Pharmaceuticals Recent Developments
6 North America
6.1 North America Brain Tumor Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Brain Tumor Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Brain Tumor Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Brain Tumor Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Brain Tumor Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Brain Tumor Therapeutics Market Dynamics
11.1 Brain Tumor Therapeutics Industry Trends
11.2 Brain Tumor Therapeutics Market Drivers
11.3 Brain Tumor Therapeutics Market Challenges
11.4 Brain Tumor Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List